The latest closing stock price for Mineralys Therapeutics as of November 08, 2024 is 14.04.
An investor who bought $1,000 worth of Mineralys Therapeutics stock at the IPO in 2023 would have $-239 today, roughly 0 times their original investment - a -12.74% compound annual growth rate over 2 years.
The all-time high Mineralys Therapeutics stock closing price was 19.14 on March 03, 2023.
The Mineralys Therapeutics 52-week high stock price is 16.91, which is 20.4% above the current share price.
The Mineralys Therapeutics 52-week low stock price is 5.85, which is 58.3% below the current share price.
The average Mineralys Therapeutics stock price for the last 52 weeks is 11.82.
An investor who bought $1,000 worth of Mineralys Therapeutics stock at the IPO in 2023 would have $-239 today, roughly 0 times their original investment - a -12.74% compound annual growth rate over 2 years.
The all-time high Mineralys Therapeutics stock closing price was 19.14 on March 03, 2023.
The Mineralys Therapeutics 52-week high stock price is 16.91, which is 20.4% above the current share price.
The Mineralys Therapeutics 52-week low stock price is 5.85, which is 58.3% below the current share price.
The average Mineralys Therapeutics stock price for the last 52 weeks is 11.82.